EVEON and Sensorion collaborating to develop an injection system for the delivery of gene therapy treatments into the inner ear

EVEON exhibited at Pharmapack - booth F68 and at Innovation Gallery, on February 1-2, 2023 in Paris (France). 

During the last years, drug delivery has evolved and new routes of administration have emerged.

Article OnDrugDelivery about the gap between patient safety and HealthCareWorkers for product preparation. And How safe and automatic, such as EVEON devices, can improve drug preparationCheckout our last article for multidose vials?

EVEON contributes to studies about feasibility of intratumoral delivery to induced glioblastoma, in a large animal model. EVEON developed the preclinical injection system for this project. Work on this subject has been published in the journal Plos One.

The project KinCellS, supported by the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, was launched on September 9th, 2020, with the consortium members : Nanobiose, project leader, EVEON and the SyMMES laboratory.

Article OnDrugDelivery about the results of work carried out in joint efforts by EVEON and LMGP in the field of protein adsorption and aggregation, and how the results of this work have led to improvements in the design of EVEON’s proprietary micropump.

EVEON is proud to be part, again in 2020, of Team Excellence - bpifrance.

EVEON is proud to be in Forbes' ranking as one of the best French inventors, thanks to its strong portfolio of patents, to its development, to R&D investment.

Supported by the European Union, the project ISIS aims to develop and industrialize a connected and secure medical device for automated drug reconstitution.